Free Trial

Zymeworks (ZYME) News Today

$8.41
0.00 (0.00%)
(As of 05:17 PM ET)
Zymeworks logo with Medical background
Q2 2024 Earnings Forecast for Zymeworks Inc. Issued By HC Wainwright (NYSE:ZYME)
Zymeworks Inc. (NYSE:ZYME - Free Report) - Research analysts at HC Wainwright decreased their Q2 2024 earnings per share (EPS) estimates for Zymeworks in a research report issued on Tuesday, June 18th. HC Wainwright analyst R. Burns now forecasts that the company will post earnings per share of (
Zymeworks logo with Medical background
Perceptive Advisors LLC Cuts Stock Position in Zymeworks Inc. (NYSE:ZYME)
Perceptive Advisors LLC lessened its position in Zymeworks Inc. (NYSE:ZYME - Free Report) by 25.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,074,807 shares of the company's stock after selling 371,316 shares during the
Zymeworks logo with Medical background
Zymeworks (NYSE:ZYME) Stock Price Up 5.7%
Zymeworks (NYSE:ZYME) Trading 5.7% Higher
Zymeworks logo with Medical background
Rubric Capital Management LP Purchases 823,990 Shares of Zymeworks Inc. (NYSE:ZYME)
Rubric Capital Management LP increased its position in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) by 31.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,475,384 shares of the company's stock after acquiring an
Zymeworks logo with Medical background
Zymeworks' (ZYME) "Neutral" Rating Reiterated at HC Wainwright
HC Wainwright restated a "neutral" rating and set a $10.00 target price on shares of Zymeworks in a research report on Thursday.
Zymeworks logo with Medical background
Zymeworks (NYSE:ZYME) Trading 8.4% Higher
Zymeworks (NYSE:ZYME) Stock Price Up 8.4%
Assenagon Asset Management S.A. Acquires Shares of 166,549 Zymeworks Inc. (NYSE:ZYME)
Assenagon Asset Management S.A. acquired a new stake in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 166,549 shares of the company's stock,
Stifel Nicolaus Reaffirms Their Buy Rating on Zymeworks (ZYME)
Zymeworks (NYSE:ZYME) Price Target Lowered to $16.00 at Citigroup
Citigroup dropped their price target on Zymeworks from $17.00 to $16.00 and set a "buy" rating on the stock in a research note on Friday.
Zymeworks (NYSE:ZYME) Shares Up 3.5%
Zymeworks (NYSE:ZYME) Trading Up 3.5%
Zymeworks (NYSE:ZYME) Trading Down 2.6%
Zymeworks (NYSE:ZYME) Shares Down 2.6%
Zymeworks (NYSE:ZYME) Stock Price Down 6.7%
Zymeworks (NYSE:ZYME) Stock Price Down 6.7%
Zymeworks Inc. (NYSE:ZYME) Shares Purchased by Wellington Management Group LLP
Wellington Management Group LLP grew its stake in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) by 177.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 156,682 shares of the company's stock after acqui
Analysts’ Top Healthcare Picks: Zymeworks (ZYME), 89bio (ETNB)
AQR Capital Management LLC Has $5.07 Million Stock Holdings in Zymeworks Inc. (NYSE:ZYME)
AQR Capital Management LLC lifted its stake in shares of Zymeworks Inc. (NYSE:ZYME - Free Report) by 70.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 799,679 shares of the company's stock after purchasing an additi
Get Zymeworks News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZYME and its competitors with MarketBeat's FREE daily newsletter.

Who are Nvidia’s Silent Partners? (Ad)

Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.

I call these Nvidia’s “Silent Partners.”

ZYME Media Mentions By Week

ZYME Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ZYME
News Sentiment

0.96

0.73

Average
Medical
News Sentiment

ZYME News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ZYME Articles
This Week

8

2

ZYME Articles
Average Week

Get Zymeworks News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZYME and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:ZYME) was last updated on 6/21/2024 by MarketBeat.com Staff

From Our Partners